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Toxoplasmosis is one of the most common opportunistic parasitic diseases in patients
living with HIV/AIDS. This study aimed to determine the seroprevalence of Toxoplasma
infection in HIV-infected patients and to identify associated risk factors in Toxoplasma
seropositive patients. This study was conducted at a regional public hospital in Hat Yai,
southern Thailand during October 2009 to June 2010. Blood samples were collected
from 300 HIV-infected patients. Each subject also answered a socio-demographic and
risk factors associated with Toxoplasma infection. The prevalence of anti-Toxoplasma
IgG antibodies in HIV-infected patients was 109 (36.3%), of which 83 (76.2%) had
past infection and 26 (23.9%) had recently acquired Toxoplasma infection as indicated
by their IgG avidity. Multivariate analysis using logistic regression showed that gender
difference (adjusted OR = 1.69, 95% CI = 1.05–2.72) was the only factor associated
with Toxoplasma infection. From the results obtained, these HIV-infected patients could
be at high risk of developing clinical evidence of severe toxoplasmosis. Therefore, it is
necessary to introduce primary behavioral practices to prevent Toxoplasma infection
among HIV-infected patients.
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INTRODUCTION
Toxoplasmosis is a clinical and/or pathological evidence of a disease caused by Toxoplasma
gondii, an obligate intracellular protozoan parasite. Toxoplasma infection aﬀects about one-third
of the world population but the majority of infected individuals are asymptomatic (Montoya
and Liesenfeld, 2004). In people who are living with HIV/AIDS, there is an increased risk of
reactivation of latent Toxoplasma infection in several organs, particularly in the brain leading
toxoplasmic encephalitis (TE) that further complicates the course of AIDS (Sukthana, 2006).
Globally, the number of patients who died from AIDS has been declining over the years due
to the introduction of highly active antiretroviral therapy (HAART). Toxoplasmosis, one of the
HIV co-infections, has, however, contributed to the burden of medical care costs (Suwanagool
et al., 1997) and to those patients who are repeatedly admitted to government hospitals
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(Solomon et al., 2006). Till date, approximately 10% of people
living with HIV/AIDS are from the Southern part of Thailand
(Ministry of Public Health [MOPH], 2011). To the best of our
knowledge, there is no epidemiological surveillance reported on
the opportunistic infections in HIV-infected patients including
toxoplasmosis in this region. Furthermore, IgG avidity testing,
a qualitative method, is the ﬁrst ever serodiagnostic method to
be introduced in diﬀerentiating chronic from recently acquired
Toxoplasma infection in these patients. This method deﬁnitely
helps in better understanding the status of Toxoplasma infection
and its proper management in HIV patients. It is, therefore,
relevant to conduct an epidemiological study of toxoplasmosis
by determining the seroprevalence, the association with risk
factors and the measurement of IgG avidity from Toxoplasma
seropositive patients.
MATERIALS AND METHODS
Study Population
This cross-sectional study was carried out at Songklanagarind
hospital, Hat Yai, Songkhla province, Thailand with the approval
from the ethical committee of the Faculty of Medicine, Prince
of Songkla University, Thailand (EC 53-080-14-1-2). The study
included 300 HIV-infected patients, who attended the outpatient
clinic and/or admitted in the ward at the Department of
Internal Medicine during October 2009 to June 2010 and their
informed consents were obtained prior to this study. The
study subjects were randomly selected from those HIV-infected
patients in any age group who had their anti-HIV antibody
status examined by screening using the ELISA test and conﬁrmed
by the western blot technique. The information on related
socio-demographic such as age, sex, and occupation as well as
risk factors associated with Toxoplasma infection, such as close
contact with cats, consumption of uncooked meats, a history
of receiving blood transfusion, and some clinical backgrounds
such as receiving primary chemoprophylaxis and/or receiving
HAART. A CD4 cell count was obtained from their hospital
recorded.
Serum Samples
Approximately 5 mL of venous blood sample was drawn from the
participating HIV patients by a venipuncture into a sterile test
tube. The sera were obtained after separation by centrifugation at
2500 × g for 5 min, and subsequently kept at −20◦C until use.
Detection of anti-Toxoplasma IgG
antibodies
The serostatus of Toxoplasma infection was screened using a
standard ELISA commercial kit (IgG-NovaLisaTM, Dietzenbach,
Germany) in accordance with the manufacturer’s instructions.
Measurement of IgG avidity
A positive sample for anti-Toxoplasma IgG antibody was also
tested for its avidity using a standard ELISA commercial kit
(IgG-NovaLisaTM, Dietzenbach, Germany); high avidity (>40%)
indicated a past infection while a low avidity (<40%) indicated a
recently acquired infection.
Statistical Analysis
Data obtained from both the questionnaire and laboratory
tests were entered and analyzed using the statistical software
SPSS version 10 (SPSS Inc., Chicago, IL, USA). The data
with quantitative variables were expressed as a mean (±SD)
and range, whereas, qualitative variables were estimated and
presented as frequencies and percentages. The Chi-square
(χ2) test or Fisher exact probability test was chosen to
determine the association between possible risk factors and
disease transmission. Multivariate analysis adjusted by multiple
logistic regressions was used to determine signiﬁcant diﬀerences
between demographics or confounding risk factors associated
with Toxoplasma infection among study subjects. The p-value of
≤0.05 was regarded as statistically signiﬁcant.
RESULTS
Demographic Profile of Study Subjects
Table 1 shows the age range of these HIV-infected patients was
21–78 with a mean of 40.4 ± 8.4 years. Majority of these patients
were in the age group of 20–39 years (150, 50%), in addition,
they were predominantly married (196, 65.3%), and were laborers
(174, 58%). About half of these patients had completed secondary
school level of education (153, 51%).
Seroprevalence of Toxoplasmosis in
HIV/AIDS Patients and in Association
with Demographic Characteristics
The seroprevalence of Toxoplasma infection in these patients was
109 (36.3%). Measurement of IgG avidity among Toxoplasma
seropositive patients showed 83 (76.2%) had high avidity
indicates past infection while 26 (23.9%) patients had low avidity
indicates recently acquired Toxoplasma infection.
Using univariate analysis, this study identiﬁed that gender
and a history of having cerebral toxoplasmosis were statistically
signiﬁcant factors associated with Toxoplasma seropositivity
(p < 0.05). The data further showed that majority of male
patients were signiﬁcantly found in the age group of 40–
59 years, and they make their living through their labor works.
It is also shown that these male patients had not received
high education, stayed outside the main city and eating of
uncooked meat; however, there was no signiﬁcant association
(Table 2). Further analysis using multivariate logistic regression
showed that gender (male) plays a signiﬁcant role in Toxoplasma
seropositivity with adjusted odds ratio of 1.69 (95% CI = 1.05–
2.72; Table 3).
The Prevalence of TE in Patients with
AIDS
The past clinical history of these patients showed that 10/300
(3.3%) of HIV/AIDS patients, aged between 28 and 52 years,
5 males, and 5 females, were diagnosed with TE prior to this
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TABLE 1 | Univariate analysis of plausible demographic characteristics, clinical profiles, and other possible risk factors associated with Toxoplasma
seropositive HIV-infected patients.
Demographic characteristics Number (%) Number IgG
positive (%)
p-Value
Age group (years) 20–39
40–59
≥60
150 (50)
143 (47.7)
7 (2.3)
46 (30.7)
60 (42)
3 (42.9)
0.125a
Sex Male
Female
157 (52.3)
143 (47.7)
66 (42)
43 (30.1)
0.031a
Marital status Single
Married
104 (34.7)
196 (65.3)
42 (40.4)
67 (34.2)
0.288a
Education Primary
Secondary
Tertiary
75 (25)
153 (51)
72 (24)
27 (36)
54 (35.3)
28 (38.9)
0.870a
Occupation Laborer
Non-laborer
Otherb
174 (58)
59 (19.7)
67 (22.3)
62 (35.6)
24 (40.7)
23 (34.3)
0.728a
Present address Songkhla
Outside
149 (49.7)
151 (50.3)
49 (46.2%)
57 (53.8)
0.378a
CD4 (cells/cumm) <200
200–499
≥500
52 (17.3)
134 (44.7)
114 (38)
22 (42.3)
54 (40.3)
33 (29)
0.111a
History of receiving chemoprophylaxisc Yes
No
63 (21)
237 (79)
24 (38.1)
85 (35.9)
0.744a
History of receiving highly active antiretroviral
therapy (HAART)
Yes
No
285 (95)
15 (5)
100 (35.1)
9 (60)
0.051a
History of toxoplasmic encephalitis (TE) Yes
No
10 (3.3)
290 (96.7)
7 (70)
102 (35.2)
0.024d
History of contact with cats Yes
No
191 (63.7)
109 (36.3)
65 (34)
44 (40.4)
0.272a
History of eating uncooked meat Yes
No
58 (19.3)
242 (80.7)
20 (34.5)
89 (36.8)
0.744a
History of blood transfusion Yes
No
4 (1.3)
296 (98.7)
3 (75)
106 (35.8)
0.106d
ap-value was evaluated by χ2 test.
bOther includes retiree, unemployed, housewives and students.
cCo-trimoxazole
dp-value was analyzed by Fisher exact probability test.
study. Our study conﬁrmed statistically signiﬁcant (p = 0.024)
sero-evidence of anti-Toxoplasma (IgG) antibodies in seven cases
(data were not shown).
Other Co-opportunistic Infections in
HIV/AIDS Patients
During the time of this study, there was no new diagnosis
of TE reported from our patients. However, patients
with Toxoplasma seropositivity and other concurrent
opportunistic diseases were found as follow: 24/72 patients
with tuberculosis (TB) had Toxoplasma seropositivity
and 18 of these TB patients subsequently developed
immune reconstitution inﬂammatory syndrome (IRIS-
TB). Toxoplasma seropositivity was also found in: 15
patients with herpes virus infections (herpes simplex
(HS) and herpes zoster (HZ) viruses), 2 patients with
cytomegalovirus (CMV) infections, 2 patients with
salmonellosis, 3 patients with histoplasmosis, 5 patients
with cryptococcal meningitis, 6 patients with penicillosis,
and 4 patients with non-tuberculous meningitis (NTM).
Overall, there was no fatal case reported at the end of this
study.
DISCUSSION
Approximately half of HIV-infected patients are co-infected
with T. gondii (Shimelis et al., 2009; Daryani et al., 2011).
In Thailand, previous studies of the prevalence of Toxoplasma
infection among HIV-infected patients found the prevalence
ranging from 22.4 to 53.7% (Wongkamchai et al., 1995;
Chintana et al., 1998; Sukthana et al., 2000; Nissapatorn
et al., 2001; Wanachiwanawin et al., 2001). In our study,
36.3% of subjects were infected with Toxoplasma. This is
higher than a study among immunocompetent pregnant women
(28.3%) in a study conducted in the same location at the
same time (Nissapatorn et al., 2011). Diﬀerences in the
sensitivity of the ELISA test kit may account for the diﬀerences
in the prevalence of Toxoplasma infection (Chemoh et al.,
2013).
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TABLE 2 | Comparison of plausible demographic characteristics, clinical profiles, and other possible risk factors between male and female HIV-infected
patients.
Demographic characteristics Number (%) p-Value
Male Female
Age group (years) 20–39
40–59
≥60
60 (38.2)
93 (59.2)
4 (2.6)
90 (62.9)
50 (35)
3 (2.1)
0.000a
Marital status Single
Married
47 (29.9)
110 (70.1)
57 (39.9)
86 (60.1)
0.092a
Education Primary
Secondary
Tertiary
33 (21)
84 (53.5)
40 (25.5)
42 (29.4)
69 (48.2)
32 (22.4)
0.248a
Occupation Laborer
Non-laborer
Otherb
103 (65.6)
40 (25.5)
14 (8.9)
71 (49.6)
19 (13.3)
53 (37.1)
0.000a
Present address Songkhla
Outside
76 (51)
81 (53.6)
73 (49)
70 (46.4)
0.648a
History of receiving chemoprophylaxis Yes
No
40 (25.5)
117 (74.5)
23 (16.1)
120 (83.9)
0.064a
Seroprevalence of Toxoplasma infection Positive
Negative
66 (42)
91 (58)
40 (28)
103 (72)
0.011a
History of contact with cats Yes
No
102 (65)
55 (35)
89 (62.2)
54 (37.8)
0.711a
History of eating uncooked meat Yes
No
37 (23.6)
120 (76.4)
21 (14.7)
122 (85.3)
0.072a
History of blood transfusion Yes
No
1 (0.6)
156 (99.4)
3 (2.1)
140 (97.9)
0.262c
ap-Value was evaluated by χ2 test.
bOther includes retiree, unemployed, housewives and students.
cp-Value was analyzed by Fisher exact probability test.
IgG avidity testing was developed to avoid the need of
conducting conﬁrmatory tests with a second serum sample
to determine, if there is a recently acquired infection (Pour
Abolghasem et al., 2011). A positive Toxoplasma IgG test with
a low avidity suggests a recently acquired infection (Liesenfeld
et al., 2001; Reis et al., 2006). Based on IgG avidity testing, 8.7%
of our subjects had a newly acquired Toxoplasma infection and
these patients were closely monitored. However, none developed
clinical toxoplasmosis during the study.
Using multivariate analysis, male gender was found to be
the only signiﬁcant risk factor for Toxoplasma infection. This is
consistent with other studies (Nissapatorn et al., 2007; Akanmu
et al., 2010). Males were found to be more susceptible to
acquire several infections due to their sex steroid hormones
that decrease immune responses and inﬂuence disease resistance
genes and their behaviors (Klein, 2000). These may be the
reasons, why the seropositivity of male HIV/AIDS patients to
Toxoplasma infection was signiﬁcantly higher than the female
HIV/AIDS patients (Roberts et al., 2001). Previously identiﬁed
risk factors, such as close contact with cats, consumption of
uncooked meats and history of receiving a blood transfusion
were not signiﬁcantly associated with Toxoplasma infection in
our study.
Reactivation of latent Toxoplasma infection is common
in immunocompromised hosts (Dahnert, 2003) making HIV
patients at higher risk for clinical toxoplasmosis. TE is the most
common neurological condition (42%) in HIV-infected patients
TABLE 3 | Multivariate logistic regression analysis of risk factors
associated with Toxoplasma seropositivity.
Demographic
characteristicsa
Adjusted OR
(95% CI)b
p-Value
Gender 1.69 (1.05–2.72) 0.042
History of receiving HAART 0.36 (0.13–1.04) 0.095
History of TE 4.30 (1.09–16.99) 0.075
aOnly risk factors with a p≤ 0.10 on univariate analysis were included in multivariate
logistic regression analysis.
bOR, odds ratio; CI, confidence interval.
(Ramirez-Crescencio and Velasquez-Perez, 2011). Ten subjects
(3.3%) in our study had a previous history of TE as diagnosed by a
combination of clinical TE: headaches, seizure, focal neurological
deﬁcits, histology and response of therapy, of these 70% (7) were
seropositive for Toxoplasma infection. This ﬁnding is similar to
another study who found some of the patients with conﬁrmed
TE were not positive for Toxoplasma antibodies (Skiest et al.,
2000).
CONCLUSION
Latent toxoplasmosis is still prevalent in our study
population. Gender was the only signiﬁcant risk factor
for Toxoplasma infection in our study. Although the
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number of HIV infected patients in Thailand has decreased
nationwide (Ministry of Public Health [MOPH], 2011), we
recommend newly infected HIV patients be warned about this
opportunistic parasitic disease during the counseling period
since both newly acquired and chronic Toxoplasma infections
in patients with AIDS are occasionally developed clinical
toxoplasmosis (Centers for Disease Control and Prevention
[CDC], 2009).
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